CHEMED CORPORATION vs SOTERA HEALTH COMPANY, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CHE and SHC diverge most: on debt / equity, CHE reads 0.17 and SHC reads 3.21; on return on invested capital, CHE reads 26.7% and SHC reads 2.3%. The rest of the comparable metrics sit closer together. On valuation, today's CHE price has a different growth bar priced in than SHC (+4.7% implied for CHE vs +18.7% for SHC); the higher figure is the steeper assumption to clear, not a better or worse stock. What CHE's price implies is a bet that sits within the historical range (whole-company basis). What SHC's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CHE | SHC |
|---|---|---|
| Price | $499.14 | $18.05 |
| Market cap | $6.6B | $5.2B |
| Sector | Medical Care | Medical Care |
| Stage | Mature | Mature |
| Implied growth (priced in) | +4.7% | +18.7% |
| P/E | 25.1 | 31.7 |
| P/B | 7.93 | 7.81 |
| P/S | 2.54 | 4.28 |
| EV/EBITDA | 16.4 | 55.8 |
| Revenue growth | +3.4% | +8.2% |
| Gross margin | — | 55.4% |
| Operating margin | 13.3% | — |
| Net margin | 10.6% | 13.4% |
| Return on equity | 33.1% | 24.6% |
| Return on assets | 17.4% | 4.9% |
| Return on invested capital | 26.7% | 2.3% |
| FCF yield | 4.7% | 2.2% |
| Dividend yield | 0.4% | — |
| Debt / equity | 0.17 | 3.21 |
| Current ratio | 0.91 | 2.80 |
| Altman Z (solvency) | 9.81 | 1.51 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.